Results 321 to 330 of about 2,299,538 (354)

Growth Retardation and Tumour Inhibition by BRCA1 [PDF]

Obstetrical & Gynecological Survey, 1996
Inherited mutations in BRCA1 predispose to breast and ovarian cancer, but the role of BRCA1 in sporadic breast and ovarian cancer has previously been elusive. Here, we show that retroviral transfer of the wild-type BRCA1 gene inhibits growth in vitro of all breast and ovarian cancer cell lines tested, but not colon or lung cancer cells or fibroblasts ...
Marilyn E. Thompson, Cheryl Robinson-Benion, Carlos L. Arteaga, Mary Claire King, Csilla Szabo, Jeffrey T. Holt, Roy A. Jensen   +6 more
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Growth inhibition by cyclosporine a and

Life Sciences, 1991
Cyclosporine A is a commonly used immunosuppressant in organ transplant. However, in addition to its nephro- and hepato-toxicity, we now report that it also exerts growth inhibiting effects in vivo and in vitro. Rats treated with daily Cyclosporine A I.P.
Jacqui Detmar, Patricia L. Chang, Vanessa J. Bennett   +2 more
openaire   +2 more sources

Inhibition of growth hormone and thyrotropin release by growth hormone-release inhibiting hormone

Molecular and Cellular Endocrinology, 1974
Abstract Addition of increasing doses of synthetic growth hormone-release inhibiting hormone (GH-RIH) leads to a progressive decrease of the basal and N 6 monobutyryl cyclic AMP-,theophylline- and prostaglandin E 2 -induced release of immunoreactive growth hormone (GH) and thyrotropin (TSH) release from rat anterior pituitary cells in monolayer ...
Fernand Labrie, Alain Bélanger, Verner R. Nelson, Manfred K. Gotz, Andrew V. Schally, Jean Côté, Jacques Drouin, Esther J. Coy, K. Sestanj, David H. Coy, Hans U. Immer, Pierre Borgeat, Muriel Savary   +12 more
openaire   +3 more sources

A Minimal Model of Tumor Growth Inhibition

IEEE Transactions on Biomedical Engineering, 2008
The preclinical development of antitumor drugs greatly benefits from the availability of models capable of predicting tumor growth as a function of the drug administration schedule. For being of practical use, such models should be simple enough to be identifiable from standard experiments conducted on animals.
MAGNI, PAOLO, DE NICOLAO, GIUSEPPE, M. Germani, G. Bianchini, M. Simeoni, I. Poggesi, M. Rocchetti   +6 more
openaire   +4 more sources

Growth-Inhibiting and Growth-Stimulating Substances

Botanical Gazette, 1924
When pots containing fertile soils are seeded to wheat or barley for continuous seasons, and successive short period crops of four to six weeks' growth are removed from such soils, it is found that the first crop is usually the largest, the immediately succeeding crops are much smaller, but some of the latter crops may be larger than some of the ...
openaire   +2 more sources

Resveratrol inhibits the growth of

The American Journal of Gastroenterology, 2000
Susan L. Pendland, Gail B. Mahady
openaire   +2 more sources

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Growth inhibition of by protamine

FEMS Microbiology Letters, 1997
H Madeira, M Morrison
openaire   +2 more sources

Inhibition of Surface Growth

Science, 1946
openaire   +4 more sources

Cancer treatment and survivorship statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Kimberly D Miller, Leticia M Nogueira, Angela B Mariotto   +2 more
exaly